November 17 - 20, 2019
Boston Marriott Copley Place
Abstract submission deadline: Thursday, September 5
Advance registration deadline: Monday, October 7
Abstract Submission and Award Application Deadline: Thursday, Sept. 5, 2019Advance Registration Deadline: Monday, Oct. 7, 2019
Conference CochairsTimothy A. Chan, Memorial Sloan-Kettering Cancer Center, New York, New YorkCharles G. Drake, Columbia University Medical Center, New York, New YorkMarcela V. Maus, Massachusetts General Hospital, Boston, MassachusettsArlene H. Sharpe, Harvard Medical School, Charlestown, Massachusetts
This AACR Special Conference on Tumor Immunology and Immunotherapy is designed to integrate multidisciplinary facets of basic cancer immunology and immunotherapy to broaden our understanding of ways to harness the immune system to treat cancer. The hallmark of this series is also to encourage the effective exchange of ideas between basic cancer immunologists, non-immunologists, and clinical oncologists in order to develop approaches that translate to outcomes. This year’s program will feature international leaders in the field, who will expand our knowledge of the microbiome; adverse immunological events; imaging and other new technologies; genetics and epigenomics of immuno-oncology; and immunological signaling pathways. These world-renowned oncologists and researchers will offer their insights on novel cell therapies, biomarkers, vaccines and adjuvants, all in the pursuit of understanding tumor evolution and creating better treatments. Please join in the conversation and network with investigators, from basic to translational scientists, from academia to industry.